Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT07352293

The Value of Methotrexate in NCES for Stable Vitiligo

Led by Cairo University · Updated on 2026-03-04

20

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if adding a six months course of Methotrexate would improve the results of non cultured epidermal suspension (NCES) in adult patients with acral and resistant vitiligo lesions over the elbows and knees. researchers will compare results of NCES in two groups one group will receive Methotrexate for 3 months prior to the procedure and 3 months after the procedure, while the other group will not receive the drug. Patients will receive PUVA hand \& feet 3 times/week for 3 months after NCES during this period they will be followed up monthly to evaluate repigmentation.

CONDITIONS

Official Title

The Value of Methotrexate in NCES for Stable Vitiligo

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with non-segmental vitiligo (NSV) with acral or resistant lesions over the elbows and knees, that has not responded to conventional treatment
  • Stability of vitiligo lesions for at least 1 year
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Segmental vitiligo
  • Active vitiligo with new lesions, expansion of old lesions, confetti-like lesions, ill-defined edges, or koebnerization within the past year
  • Age under 18 years
  • Pregnant females
  • Patients with hematologic, liver, kidney disease, or chronic infection
  • Use of topical treatment within the past month or systemic treatment within the past 3 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dermatology Outpatient Clinic, Kasr al Ainy Teaching Hospital, Cairo University

Cairo, Egypt

Actively Recruiting

Loading map...

Research Team

N

Nanis Ragab, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here